Prognostic effect of cytoreductive nephrectomy in synchronous metastatic renal cell carcinoma: a comparative study using inverse probability of treatment weighting.
Klatte, Tobias
Prognostic effect of cytoreductive nephrectomy in synchronous metastatic renal cell carcinoma: a comparative study using inverse probability of treatment weighting. [electronic resource] - World journal of urology Mar 2018 - 417-425 p. digital
Publication Type: Comparative Study; Journal Article
1433-8726
10.1007/s00345-017-2154-x doi
Aged
Anilides--therapeutic use
Antibodies, Monoclonal--therapeutic use
Antineoplastic Agents--therapeutic use
Carcinoma, Renal Cell--blood
Cohort Studies
Combined Modality Therapy
Cytoreduction Surgical Procedures--methods
Female
Humans
Indazoles
Indoles--therapeutic use
Kaplan-Meier Estimate
Kidney Neoplasms--blood
Liver Neoplasms--drug therapy
Lung Neoplasms--drug therapy
Male
Middle Aged
Molecular Targeted Therapy
Neoplasm Metastasis
Nephrectomy--methods
Nivolumab
Probability
Prognosis
Proportional Hazards Models
Pyridines--therapeutic use
Pyrimidines--therapeutic use
Pyrroles--therapeutic use
Retrospective Studies
Sex Factors
Sulfonamides--therapeutic use
Sunitinib
Survival Rate
Thrombocytosis--blood
Prognostic effect of cytoreductive nephrectomy in synchronous metastatic renal cell carcinoma: a comparative study using inverse probability of treatment weighting. [electronic resource] - World journal of urology Mar 2018 - 417-425 p. digital
Publication Type: Comparative Study; Journal Article
1433-8726
10.1007/s00345-017-2154-x doi
Aged
Anilides--therapeutic use
Antibodies, Monoclonal--therapeutic use
Antineoplastic Agents--therapeutic use
Carcinoma, Renal Cell--blood
Cohort Studies
Combined Modality Therapy
Cytoreduction Surgical Procedures--methods
Female
Humans
Indazoles
Indoles--therapeutic use
Kaplan-Meier Estimate
Kidney Neoplasms--blood
Liver Neoplasms--drug therapy
Lung Neoplasms--drug therapy
Male
Middle Aged
Molecular Targeted Therapy
Neoplasm Metastasis
Nephrectomy--methods
Nivolumab
Probability
Prognosis
Proportional Hazards Models
Pyridines--therapeutic use
Pyrimidines--therapeutic use
Pyrroles--therapeutic use
Retrospective Studies
Sex Factors
Sulfonamides--therapeutic use
Sunitinib
Survival Rate
Thrombocytosis--blood